Paper

Evolutionary shortcuts via multinucleotide substitutions and their impact on natural selection analyses (Lucaci et al. 2023)

0. Citation-identity warning (read first)

The invocation supplied DOI 10.1101/2022.12.02.518889 but paired it with the title “Extra base hits: Widespread empirical support for instantaneous multiple-nucleotide changes.” These do not match. Per the bioRxiv/journal record:

  • DOI 10.1101/2022.12.02.518889 is the preprint of “Evolutionary shortcuts via multinucleotide substitutions and their impact on natural selection analyses” — the BUSTED+MH / BUSTED+S+MH paper. This is the source summarized here (matches the dir id busted-mh, year 2023, and the guidance topic).
  • “Extra base hits: widespread empirical support for instantaneous multiple-nucleotide changes” is a separate, earlier paper by an overlapping author set: Lucaci AG, Wisotsky SR, Shank SD, Weaver S, Kosakovsky Pond SL. bioRxiv 10.1101/2020.05.13.091652 → PLoS ONE 2021;16(3):e0248337. It is the 35,000-alignment “1H/2H/3H model preference” survey, and it is cited within the present paper (as Lucaci et al. 2021) as prior work. It is NOT this source.

The title in the invocation is a paste error; the DOI is authoritative and points to the paper below.

1. Citation

  • Authors: Alexander G. Lucaci, Jordan D. Zehr, David Enard, Joseph W. Thornton, Sergei L. Kosakovsky Pond.
  • Title (published): “Evolutionary Shortcuts via Multinucleotide Substitutions and Their Impact on Natural Selection Analyses.” (preprint spelled it “multi-nucleotide”; journal spells “Multinucleotide”).
  • Venue read: Molecular Biology and Evolution 40(7):msad150. Published 3 Jul 2023 (collection date 2023 Jul). PMID 37395787; PMCID PMC10336034. DOI 10.1093/molbev/msad150.
  • Preprint: bioRxiv 10.1101/2022.12.02.518889. v1 posted 2022-12-03 (author list Lucaci, Zehr, Kosakovsky Pond); v2 & v3 posted 2023-03-10 (v3 author order: Lucaci, Zehr, Enard, Thornton, Kosakovsky Pond). Preprint license CC-BY-NC.
  • Access date: 2026-07-05.
  • Supersession: The peer-reviewed MBE version supersedes the preprint. I read the published MBE version (freely readable, more permissive license). Preprint recorded above for pinning; not re-read line-by-line — treat MBE msad150 as canonical.

2. Access note

Full text obtained via Europe PMC full-text XML for PMC10336034 (complete article body, tables, methods, references). bioRxiv HTML/PDF was Cloudflare-blocked; the biorxiv REST API supplied version/date/license metadata. No paywall boundary — the entire published article was read. Figures were read as captions only (image content not inspected).

3. License / quoting mode

Version read (MBE msad150) is Open Access under Creative Commons Attribution License (CC-BY 4.0) — “permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.” This is permissive → short verbatim load-bearing quotes are allowed (§7). (The bioRxiv preprint is the more restrictive CC-BY-NC, but the canonical version I quote is CC-BY.)

4. Thesis (1 sentence)

Failing to model instantaneous multinucleotide (multi-hit, MH) substitutions and site-to-site synonymous rate variation (SRV) jointly biases dN/dS-based selection tests toward false positives; the authors build an integrated BUSTED-class framework (+S, +MH, +S+MH) plus a model-averaging procedure that controls false positives while retaining power, and recommend routine inclusion of MH.

5. Problem & context

  • dN/dS (ω) codon-substitution models are the workhorse of selection detection but rest on decades-old simplifying assumptions. Two are known to be violated: (a) synonymous rate is constant across sites (SRV violation), and (b) all multinucleotide instantaneous substitutions have zero rate.
  • Standard codon models set the instantaneous rate for every multinucleotide substitution to zero, forcing e.g. ACC → AGG to be explained as successive single-nucleotide steps ACC → ACG → AGG.
  • Empirically, replication errors produce multinucleotide (MH) mutations accounting for ~1–3% of all mutations via several mechanisms (e.g. polymerase ζ). Prior work showed a few-percent MH rate yields uncontrolled false-positive rates for episodic diversifying selection (EDS).
  • Gap addressed: MH and SRV had not been modeled jointly, and no framework existed to test positive selection while simultaneously accommodating both.

6. Method / approach

Four nested BUSTED-class models (each a random-effects branch–site test for a nonzero fraction of branch–site combinations with ω>1):

  • BUSTED — baseline; K(=3)-bin discrete ω distribution; no SRV; no MH.
  • +S — adds site-to-site synonymous rate variation (L(=3)-bin unit-mean GDD on synonymous rate αₛ).
  • +MH — adds alignment-wide double- (δ) and triple- (ψ) nucleotide substitution rates; no SRV.
  • +S+MH — adds both SRV and MH. (This paper’s net-new model.)
  • Nesting: BUSTED ⊂ +S ⊂ +S+MH and BUSTED ⊂ +MH ⊂ +S+MH. Compared via AICc or nested LRTs.
  • Defaults: K=3 ω categories, L=3 synonymous categories (user-tunable). GTR nucleotide model (5 θ params, θ_AG=1). Codon frequencies via CF3×4. ω distribution: 0 ≤ ω1 ≤ ω2 ≤ 1 ≤ ω3.

Rate-matrix parameterization (instantaneous rate q_ij between sense codons):

  • 1-step syn: αₛ θ_ij π_j; 1-step nonsyn: αₛ ω_bs θ_ij π_j.
  • 2-step syn: δ αₛ ∏θ π; 2-step nonsyn: δ αₛ ω_bs ∏θ π.
  • 3-step syn: ψ αₛ ∏θ π; 3-step nonsyn: ψ αₛ ω_bs ∏θ π.
  • A single ω_bs multiplies ALL nonsynonymous rates (1H, 2H, and 3H alike). There is no separate “omega” for double or triple hits; MH is carried entirely by the scalar rates δ (2H) and ψ (3H).

EDS test: LRT of full model vs. constrained model with ω3 := 1. Critical values from a 50:50 mixture of χ²₀ and χ²₂. +S+MH reduces to +S by setting MH rates to 0. Test that δ=ψ=0 uses a conservative χ²₂.

Model averaging (recommended endpoint): p_MA = Σ_m p_m w_m, where p_m is model m’s EDS p-value and w_m is its Akaike weight w_m = exp(−ΔAICc_m/2) normalized to sum to 1 over the four models. Interprets as ~P(model=m | data)-weighted p-value. Averages away a discordant EDS call from a credible alternative.

Interpreting MH magnitude: δ, ψ raw values are not directly biologically interpretable (rate matrix terms are further multiplied by nucleotide-rate and frequency terms). Biologically meaningful quantities are the fractions of total branch length attributable to 2H and 3H: B_2H/B and B_3H/B, where B(·)=Σ_{i≠j} q_ij π_j and B_2H/B_3H restrict the sum to codon pairs differing at 2/3 positions.

Data:

  • 21 diverse benchmark alignments (historically important selection-analysis datasets; viral, vertebrate, mammalian, plant, bacterial).
  • Large empirical screen: 9,861 orthologous coding alignments, 24 mammalian species, from Enard et al. 2016 (viruses-drive-mammalian-protein-adaptation dataset). Trees via RAxML. [Note: the published Introduction states “9,181” once — an internal typo; Methods, Results, and Table 4 consistently use 9,861, which is the correct dataset size.]
  • Simulations: 4-taxon null/power sims (800 codons, HKY85 κ=2) varying δ, ψ, branch lengths, ω3; plus empirical-driven sims from the benchmark and Enard datasets.

Software: Implemented in HyPhy version 2.5.42 or later (BUSTED+MH, +S+MH in the standard HyPhy library). Snakemake model-testing wrapper BUSTED_ModelTest at https://github.com/veg/BUSTED_ModelTest; HBL source at https://github.com/veg/hyphy. Enard data at Dryad doi:10.5061/dryad.fs756; synthetic data at https://data.hyphy.org/web/busteds-mh/.

7. Load-bearing statements — VERBATIM (permissive CC-BY 4.0; short quotes)

  1. Mechanism of false ω>1 from MH (Introduction): “when a standard model ‘crams’ multiple nonsynonymous single-nucleotide substitutions onto a short branch to explain a nonsynonymous MH substitution, the dN/dS ratio estimate will be artificially inflated to accommodate this.”
  2. δ / ψ definitions (Methods): “δ is the rate for two substitutions relative to the one substitution synonymous rate (baseline), ψ is the relative rate for nonsynonymous three substitutions.”
  3. δ/ψ not directly interpretable (Methods): “Parameter values of δ, ψ are not directly biologically interpretable, because the corresponding q_ij rate matrix terms are additionally multiplied by nucleotide rate parameters and frequency terms.”
  4. CLI (functional string) (Implementation): “You can run this option using the ‘—multiple-hits’ option from the command line with either ‘Double’ to consider DH substitutions or ‘Double+Triple’ to consider DH and TH substitutions.”
  5. Absorption → false positives (Results): “the +S model appears to ‘absorb’ unmodeled multiple-hit substitutions into biased ω estimates, which leads to catastrophically high rates of false positives.”

8. Key claims / findings (atomic)

  • Both MH and SRV are ubiquitous in empirical alignments; incorporating them gives a ~1.4-fold reduction in whether positive selection is detected and shifts inferred rate distributions.
  • SRV (+S) support is strong for all 21 benchmark datasets; further MH support (+S+MH preferred by AICc) in 12/21. EDS-detection count falls from 14/21 (BUSTED) to 9/21 (+S+MH).
  • In every substantively discordant benchmark case, +S+MH did not detect selection while +S did — i.e. adding MH makes the test more conservative. Manual inspection points to MH along shorter tree branches as the driver of the difference. Model agreement across all four models: 15/21; best two models (+S, +S+MH): 17/21 (Cohen’s κ = 0.63, “substantial”).
  • Simulations: as 2H rate δ rises, +S false-positive rate climbs to 100% with increasingly biased ω3; +S+MH and the model-averaged approach keep FPR nominal/conservative. Same pattern for 3H rate ψ. FPR inflation is worst at short branches (~0.05) — long branches reach 2H via consecutive 1H steps, so gain little from instantaneous 2H; very short branches carry no signal.
  • Power: when δ=0, +S+MH loses a little power vs +S, but model-averaging rescues most of it. When δ>0, +S’s apparent extra power comes at the cost of dramatically upward-biased ω3.
  • Large screen (9,861 mammalian alignments): best-fit model counts (rank 1) — +S 8,943; +S+MH 821; BUSTED 93; +MH 4. ~10% of alignments best fit by an MH-supporting model. 2H/3H substitution fraction means: 0.3% / 0.07% overall; 6.2% / 5.6% among MH-best-fit alignments.
  • Raw EDS detection rates on the screen: BUSTED 28.4% (2,805/9,861); +S 26.4%; +MH 8.4% (826); +S+MH 10.0% (984); best-model 24.6% (2,425); model-averaged 19.3% (1,908). Only 515 alignments are called by all six criteria.
  • Under FDR correction (Benjamini-Hochberg, q≤0.2): BUSTED/+S essentially unchanged; +MH and +S+MH drop ~3-fold; model-averaged drops modestly 19.3%→15.5%.
  • ~80% of positively selected genes are still robustly detected when MH is accounted for via model averaging — MH confounding is framed as a “second-order” effect vs SRV (which affects nearly all genes), but still worth routine inclusion.
  • EDS detection is driven by very few sites: median ~3 sites and ~20–30 (branch,site) pairs carry the majority of EDS signal per alignment; for ~5–10% of detections most support comes from a single site.
  • Runtime (24-seq alignments, 4 cores AMD EPYC 7702), relative to BUSTED: +S 3.3×, +MH 6.1×, +S+MH 28.6×.
  • Practical recommendation: fit multiple BUSTED-class models and use the model-averaged EDS call (better power/FPR tradeoff than picking the single best-fit model or requiring model consensus).

9. Failure modes / invalidity patterns (referee-relevant)

  • Primary invalidity: standard single-hit codon models (BUSTED, and +S which lacks MH) produce false-positive EDS and inflated ω whenever real 2H/3H substitutions are present, especially concentrated on short branches. Symptom: ω3 estimate balloons; FPR up to 100% in simulation.
  • Diagnostic — model discordance: +S detects EDS but +S+MH (better or comparable AICc) does not → the +S signal is suspect (likely MH-driven). In this paper’s discordant cases, higher δ/ψ MLEs and large ω3(+S) − ω3(+S+MH) gaps (median 24.7 vs 0.01) accompany the false +S calls.
  • Diagnostic — single-site/single-substitution dependence: worked HIV-1 vif example — a single triple-nucleotide substitution CAG (Q) → GCA (A) on a terminal branch at codon 6 carries the bulk of the +S EDS signal; masking that one codon (GCA) with gaps makes +S EDS nonsignificant, and +S+MH already removes the signal. Rule of thumb offered: if only a few (branch,site) pairs give empirical Bayes factors >100, or a single site supplies >80% of the alignment-wide LRT statistic, and +S+MH shows no EDS → manually inspect for local alignment error / MH artifact. They flagged 172 such screen datasets.
  • Site/branch support tools: evidence ratios (ER; ratio of per-site likelihoods between two models) identify sites preferring MH models; empirical Bayes factors (EBF) locate branch–site “hot-spots” for ω3>1, δ>0, or ψ>0. EBFs are noisy — exploratory use only.
  • Overfitting guard: the +S+MH / +MH implementation warns the user when rate categories collapse to near-identical values or very low frequencies. β-globin is a worked overfitting case where +S+MH’s loss of significance is not a real MH signal (not supported by AICc or nested LRT, P≈0.5).
  • Parameter-misreading trap: interpreting the raw δ or ψ magnitude (or expecting an “ω_DH”>1) as the MH signal is wrong — δ/ψ are not directly interpretable; use B_2H/B and B_3H/B fractions. Do not read δ>1 as “multi-hit present.”

10. What the source does NOT address (confident silences)

  • MH substitutions spanning codon boundaries are explicitly not modeled (a deliberate, conservative simplification preserving codon-level site independence).
  • ω that depends on the amino acids exchanged (amino-acid preference/exchangeability heterogeneity) is not modeled; flagged as an open parameterization problem.
  • Transversion enrichment of MNMs (MNMs skew toward transversions → nonsynonymous) is not incorporated, though acknowledged as another FPR-inflating factor.
  • Alignment generation / data-quality assurance is out of scope (only post-hoc robustness tools given).
  • No claim that MH is concentrated in any specific named taxon such as Plasmodium or Trypanosoma (see §12) — the paper’s stance is that MH occurs broadly across diverse taxonomic groups.

11. Open questions / ambiguities left unresolved

  • Which biological mechanisms and mutational-spectrum details underlie MH in natural populations (calls for experimental / CRISPR-informed follow-up).
  • How to incorporate codon-boundary-spanning MH, amino-acid-dependent ω, and transversion bias into a tractable Markov model without intractable computation.
  • General thresholds for the single-site-dependence heuristics (EBF>100, 80%-of-LRT) are offered as rules of thumb, not calibrated cutoffs.

12. Guidance answers

Q1 — Mechanism: how do MNMs create false ω>1 in single-hit codon models? Single-hit models set every multinucleotide instantaneous rate to zero, so a real 2H/3H change (e.g. a nonsynonymous double substitution within a codon) must be explained as several successive single-nucleotide steps. When those forced intermediate steps are nonsynonymous and are packed onto a short branch, the model inflates ω to accommodate them (§7 quote 1). Verbatim: “when a standard model ‘crams’ multiple nonsynonymous single-nucleotide substitutions onto a short branch to explain a nonsynonymous MH substitution, the dN/dS ratio estimate will be artificially inflated to accommodate this.” Confirmed in simulation: +S “absorbs” unmodeled MH into biased ω, driving FPR up to 100% (§7 quote 5). Long branches are largely immune (multiple consecutive 1H steps are already easy), so short branches carrying MH are the specific hazard.

Q2 — What BUSTED-MH adds; the CLI option; the multi-hit rate parameter name & interpretation.

  • The models are named BUSTED+MH (MH without SRV) and BUSTED+S+MH (MH with SRV) — not literally “BUSTED-MH”. They add two alignment-wide scalar rates: δ (delta) = double-hit (2H) rate and ψ (psi) = triple-hit (3H) rate, both relative to the single-substitution synonymous baseline (§7 quote 2, verbatim).
  • CLI (functional string, verbatim): --multiple-hits with argument Double (double hits only) or Double+Triple (double + triple). The guidance’s --multiple-hits Double+Triple matches exactly. HyPhy ≥ 2.5.42.
  • Correction to the skill’s claim “omega_DH>1 indicates multi-hit”: there is no parameter named omega_DH (or any per-hit ω). A single ω (ω_bs) multiplies all nonsynonymous rates regardless of 1/2/3 hits; multi-hit is captured by δ and ψ, not by an omega. Moreover δ and ψ are not directly biologically interpretable (§7 quote 3, verbatim) — their raw magnitude is not a clean “MH present” threshold. The interpretable quantities are the branch-length fractions B_2H/B and B_3H/B (the fraction of substitutions attributable to 2H / 3H). So a correct restatement is: “nonzero δ (and/or ψ), and a non-trivial B_2H/B (B_3H/B) fraction, indicate multi-hit,” and MH’s practical effect is to lower inferred ω and remove spurious EDS, not to be read off an ω>1 on double hits.

Q3 — Diagnostics for when MNMs drive a signal; which taxa/genes most affected.

  • Diagnostics (see §9): +S-vs-+S+MH EDS discordance; nonzero δ/ψ MLEs with meaningful 2H/3H fractions; evidence ratios and empirical Bayes factors to localize MH-driven sites/branches; the single-site heuristic (few (branch,site) pairs with EBF>100, or one site >80% of the LRT) prompting manual alignment inspection; the HIV-1 vif codon-masking demonstration.
  • Taxa/genes: the paper reports MH occurs broadly across diverse taxonomic groups and does not single out the guidance’s hypothesized viral/Plasmodium/Trypanosoma set. Empirically, high-divergence viral alignments show strong MH (e.g. tick-borne Flavivirus NS5 — a high-divergence alignment with 51 inferred triple-nucleotide events; Streptococcus PTS had notably high 3H fractions; SARS-CoV-2 S, IAV H1N1/H3N2, HIV rt/vif, Hepatitis D antigen, rbcL (plant), mammalian mtDNA also feature). No mention of Plasmodium or Trypanosoma — that part of the guidance hypothesis is unsupported by this source.

Must-quote (license check): Done — I read the CC-BY 4.0 published MBE version, so short verbatim quotes are permitted (§7). CLI flags and δ/ψ parameter names are functional strings, reproduced verbatim regardless of license.